VIENNA, Va., July 7, 2021 /PRNewswire/ — With President Biden urging the nation to increase COVID-19 vaccinations, Allergy & Asthma Network, a national nonprofit patient education and advocacy organization, is releasing an innovative tool that will ease vaccine decision-making, especially for people of color and their doctors.
Allergy & Asthma Network partnered with SDMCentral, a LatinX-founded technology company in Madison, Wisconsin, to develop a Shared Decision Making tool that is conveniently designed for a desktop computer, tablet or mobile phone. It can be used in a clinic, home or other gathering place.
The Shared Decision Making took can be accessed here: https://allergyasthmanetwork.sdm.health/
“We know that most people want to make a decision about health care treatment as a partner with their doctors,” says Sally Schoessler, Allergy & Asthma Network’s Director of Education. “With COVID-19, owning the decision to get the vaccine is paramount.”
African Americans, Latinos and Native Americans have been disproportionately impacted by COVID-19. These groups are experiencing higher rates of cases, hospitalizations and deaths.
Shared Decision Making encourages people to take a more central and active role in their health by working with their doctors to participate in the choices involving treatments. Shared Decision Making is evidence-based and balances risks with results. Research shows that it gives patients more certainty and less anxiety about treatments, increases adherence and improves health outcomes.
The Shared Decision Making tool also helps clinicians better understand patient preferences and cultural values. People of color may want to know if the vaccine is safe and effective, get accurate information about side effects and find out if it is convenient to get the shot.
“Our goal is to use technology and smart content to reach out to patients, especially those of color, with this COVID-19 tool,” SDMCentral CEO Daniel Guerra, Jr. says.
About Allergy & Asthma Network
Allergy & Asthma Network is the leading nonprofit patient outreach, education, advocacy and research organization for people with asthma, allergies and related conditions. Our patient-centered network unites individuals, families, healthcare professionals, industry and government decision makers to improve health and quality of life for Americans with asthma and allergies. We specialize in making accurate medical information understandable to all while promoting evidence-based standards of care. Learn more at AllergyAsthmaNetwork.org.
About SDMCentral
SDMCentral, founded by a Madison, Wisconsin LatinX entrepreneur, creates Shared-Decision Making Aids for health care professionals and patients who want to be better partners in decisions about treatment plans for chronic disease.
Contact:
Gary Fitzgerald
Allergy & Asthma Network
gfitzgerald@allergyasthmanetwork.org
703-641-9595
Daniel Guerra, Jr., CEO
SDM Analytics
dguerrajr@altuscampus.com
608-212-2391
View original content:https://www.prnewswire.com/news-releases/new-tool-helps-people-make-informed-decision-on-covid-19-vaccine-301327429.html
SOURCE Allergy & Asthma Network
Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…
YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…
WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development…
TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or…